Salute e Benessere

Sports Medicine Market to be Worth $9.4 Billion by 2030: Grand View Research…

Read 127-page market research report, "Sports Medicine Market Size, Share & Trends Analysis Report By Product Type (Body Reconstruction & Repair, Body Support & Recovery), By Application (Knees, Shoulders, Ankle & Foot), By Region, And Segment Forecasts, 2023 - 2030", published by Grand View Research. Read 127-page market research report, " Sports Medicine Market Size, Share & Trends Analysis Report By Product Type (Body Reconstruction & Repair, Body…
PR Newswire
29/06/2023

Berlin Heals Holding AG Successfully Completes Financing Round for Ongoing…

Marko Bagaric, Chief Executive Officer, Berlin Heals Holding AG comments: Marko Bagaric, Chief Executive Officer, Berlin Heals Holding AG comments: "We have initiated the financing round with the objective to complete the CE-certification study swiftly and successfully. I am particularly delighted that we could win the Swiss company Fumedica, a special provider in heart surgery and invasive cardiology, as a new investor. Fumedica, in fact, could play an important role in the initial...
PR Newswire
29/06/2023

Positive results in uPAR-PET/MR Phase II study in brain cancer: Curasight

Results from the study, carried out at Rigshospitalet in Copenhagen, will be presented at the World Molecular Imaging Congress (WMIC) in Prague, September 2023. Results from the study, carried out at Rigshospitalet inCopenhagen, will be presented at the World Molecular Imaging Congress (WMIC) inPrague,September 2023. "We are extremely pleased that the brain cancer study using the uTRACE ® technology has now reported positive results. Not only does the study demonstrate how uTRACE...
PR Newswire
29/06/2023

Vesalius Biocapital Announces First Close of Fourth Fund Raising EUR 95 Million

Commenting on the first close, Stéphane Verdood, Managing Partner at Vesalius Biocapital IV said: Commenting on the first close, Stéphane Verdood, Managing Partner at Vesalius Biocapital IV said: "Our successful track record placed us in a strong position to attract high quality investors such as the EIF (European Investment Fund) to Vesalius Biocapital IV. Furthermore, it is fantastic validation of our investment approach and strategy that a significant number of investors in our…
PR Newswire
29/06/2023

SKF and Sinoma Nitride accelerate large-scale application of hybrid ceramic ball…

Henry Wang, President Industrial Region China and North-East Asia at SKF, says: "By working in a localized production of ceramic balls with Sinoma Nitride, we will have the opportunity to continue to optimize the end-to-end production chain and to accelerate the development of the Electric Vehicle industry." Henry Wang, President Industrial Region China and North-East Asia at SKF, says: "By working in a localized production of ceramic balls with Sinoma Nitride, we will have the…
PR Newswire
29/06/2023

Devyser Launches Two New Genetic Testing Solutions for Hereditary Cancer

Devyser LynchFAP provides a comprehensive solution to analyze PMS2 and 9 other genes associated with hereditary colorectal cancer syndromes. Devyser LynchFAP is designed to overcome one of the greatest challenges for Lynch syndrome genetic testing - the localization of genetic variants to PMS2 and its pseudogene PMS2CL. Devyser LynchFAP is the first commercial library prep kit to allow this specific analysis of the PMS2 gene. Devyser LynchFAP provides a comprehensive solution to analyzePMS2...
PR Newswire
29/06/2023

Implantica Further Expands its Commercial Footprint in Italy

"This minimally invasive procedure restores the normal anatomy of the esophageal-gastric junction so that it can prevent reflux," said Dr. Vincenti. "Unlike traditional surgical interventions, RefluxStop does not have side effects such as difficulty swallowing the food bolus, gas bloating, etc. " "This minimally invasive procedure restores the normal anatomy of the esophageal-gastric junction so that it can prevent reflux," said Dr. Vincenti. "Unlike…
PR Newswire
29/06/2023

EssilorLuxottica and Jimmy Choo announce a ten-year licensing agreement

EssilorLuxottica and Jimmy Choo announcea ten-year licensing agreementCharenton-le-Pont, France and London , UK(June29 ,2023 –8:00 am CEST)– EssilorLuxottica and Jimmy Choo announced today that they have signed an exclusive license agreement for the design, manufacture, and worldwide distribution of Jimmy Choo Eyewear. The agreement will be effective from January 1, 2024 until December 31, 2028, with an automatic renewal option of an additional...
Nasdaq GlobeNewswire
29/06/2023

Junshi Biosciences Announces Initiation of Phase 3 Study of Tifcemalimab plus…

/JS004), an anti-BTLA monoclonal antibody used in combination with toripalimab, an anti-PD-1 monoclonal antibody, as consolidation therapy for patients with limited-stage small cell lung cancer without disease progression following chemoradiotherapy may proceed. Junshi Biosciences will officially initiate the phase 3 clinical study in the near future. According to GLOBOCAN 2020, lung cancer is a form of malignant tumor with the highest incidence rate and mortality in China. Lung cancer can...
Nasdaq GlobeNewswire
29/06/2023

Press Release: Vaccines R&D pipeline raises the bar in RSV, influenza…

VaccinesInvestor Event Vaccines R&D pipeline raises the bar in RSV, influenza, meningitis, and pneumococcal diseaseSanofi reaffirms ambition to deliver >€10bn in annual vaccines sales by 2030, fueled by an accelerated pace of innovationIntent to start at least 5 innovative Phase 3 vaccine programs by 2025Paris, June 29 , 2023. Today Sanofi is hosting a Vaccines Investor Event dedicated to its pipeline with key members of its leadership team. The event will...
Nasdaq GlobeNewswire
29/06/2023

Santhera Publishes Timeline of the Reverse Share Split

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO.Ad hoc announcement pursuant to Art. 53 LR Pratteln, Switzerland, June 29 , 2023 – Santhera Pharmaceuticals (SIX: SANN) announces the timeline of the reverse share split in the ratio 10:1 which was approved by shareholders at the Annual General Meeting held on June 27, 2023 , with a large majority. June 30, 2023:...
Nasdaq GlobeNewswire
29/06/2023

Mindray's MSCI ESG rating jumps to AA level, the highest for A-share listed…

Mindray places employees at the center of the sustainable development strategy. In 2022, the company is committed to attracting top talent from universities around the world and expert talent to build a diversified global talent team. The company has experienced an increasing number of employees worldwide for three consecutive years. Diversity, equality and inclusion represent fundamental components of Mindray's core values. Consequently, in 2022, Mindray updated and upgraded multiple systems…
PR Newswire
29/06/2023

Casio to Release Dust- and Mud-Resistant G-SHOCK with Dual-Layer LCD for…

TOKYO, June 29, 2023 /PRNewswire/ -- Casio Computer Co., Ltd. announced today the release of the latest addition to the G-SHOCK brand of shock-resistant watches. The new GW-9500, which belongs to the dust- and mud-resistant MUDMAN series of timepieces designed to perform in harsh land environments, features a dual-layer LCD for improved readability of the digital compass and a slimmer size for an even more comfortable fit. TOKYO,June 29, 2023/PRNewswire/ -- Casio Computer Co., Ltd...
PR Newswire
29/06/2023

Ipsen announces positive outcome of FDA Advisory Committee on investigational…

Advisory committee voted 10 for and 4 against that evidence from the Phase III MOVE study show palovarotene is an effective treatment in patients with the ultra-rare bone disease fibrodysplasia ossificans progressiva (FOP)Advisory committee further voted 11 for and 3 against on the benefits of palovarotene outweighing the risks, for the treatment of patients with FOPFDA PDUFA action date is anticipated by August 16, 2023PARIS, FRANCE ,29 June 2023 – Ipsen (Euronext: IPN; ADR:...
Nasdaq GlobeNewswire
29/06/2023

Alvotech Provides Regulatory Update on Second Biologics License Application for…

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today that the US Food and Drug Administration (FDA) has issued a complete response letter (CRL) for Alvotech's second Biologics License Application (BLA) for AVT02, a high-concentration biosimilar candidate for Humira® (adalimumab). As the second of two BLAs submitted for AVT02, this BLA contained data to support approval as a...
Nasdaq GlobeNewswire
29/06/2023

Cellectis S.A. Reports Results from Annual Shareholders' General Meeting Held on…

thfloor, 75013 Paris, France.At the meeting, during which more than 72% of shares were exercised, Resolutions 1 through 28 were adopted and resolution 29 was rejected, according to the management recommendations.The detailed results of the vote and the resolutions are available on the company's website:https://www.cellectis.com/en/investors/general-meetings/About Cellectis Cellectis is a clinical-stage biotechnology company using its pioneering gene-editing platform to develop...
Nasdaq GlobeNewswire
28/06/2023

Avanos Medical Supports New Interventional Procedure Recommendations from the…

From the NICE announcement: "Radiofrequency energy is used to denervate the target nerves. The radiofrequency energy can be delivered as conventional radiofrequency, cooled radiofrequency or pulsed radiofrequency. The aim is to reduce pain and delay the need for knee arthroplasty. There is good evidence to show that this procedure relieves pain in the short term. There are no major safety concerns, and the complications, including numbness, are well recognised." From the NICE…
PR Newswire
28/06/2023

Intracardiac Echocardiography Devices Market size to grow by USD 11.5 billion…

Report Link with All Related Graphs & Charts:https://www.fnfresearch.com/intracardiac-echocardiography-devices-market Intracardiac Echocardiography Devices Market: Overview Intracardiac echocardiography (ICE) is a modern and unique medical technique used for imaging and providing high-definition, superior-resolution visualization of cardiac units and structures along with continuous and accurate monitoring of the exact location of the catheter in the heart. The images...
PR Newswire
28/06/2023

Phaxiam Therapeutics announces its new mnemonic code on Euronext and Nasdaq…

Phaxiam Therapeutics announces its new mnemonic code on Euronext and Nasdaq: PHXMLyon (France) and Cambridge (MA, US), June 28, 2023 - Phaxiam Therapeutics (Nasdaq & Euronext: FR0011471135), announces change of the mnemonic code of its share from ERYP to PHXM, following the merger between ERYTECH and PHERECYDES. The change has been notified by Euronext and will be effective from June 29, 2023.Company name: Phaxiam TherapeuticsISIN code: FR0011471135 Mnemonic: PHXM ...
Nasdaq GlobeNewswire
28/06/2023

GN announces divestment of BelAudição

Continued execution of new capital plan to strengthen capital structure and drive growth Today, GN has signed an agreement to divest BelAudição, Unipessoal Lda (“BelAudição”) to MCH Private Equity. BelAudição is the owner of the leading retailer of hearing aid solutions in Portugal, AudiçãoActiva, with around 50 hearing aid stores and 2022 revenues of around EUR 35 million and topline growth of 24%.MCH Private Equity is an independent private equity firm based on the Iberian Peninsula...
Nasdaq GlobeNewswire
28/06/2023

Casino Group Communication

Proposals made by the Casino group to the stakeholders in the conciliation proceedings Paris, 28 June 2023Summary of the Group's financial debt structureIn addition to its operating debt and to certain financial debts issued by its operating subsidiaries 1, the Group's financial indebtedness is composed, as of the date hereof, of the following instruments issued by Casino, Guichard-Perrachon, Casino Finance and Quatrim:InstrumentAmount (in principal)Maturity...
Nasdaq GlobeNewswire
28/06/2023

Developing a Care Pathway for Multicancer Early Detection Technologies: What…

The Multicancer Early Detection Consortium released a new paper, written by their Care Delivery Workgroup, outlining recommendations and important considerations for providers on the use of MCED tests. The paper aims to inform providers on how these emerging technologies work and complement existing cancer screening practices. It is a crucial first step in successfully integrating MCED tests across the cancer care continuum. TheMulticancer Early Detection Consortiumreleased a new paper,...
PR Newswire
28/06/2023

Wellcome and the Gates Foundation to Fund Late-Stage Development of a…

In 2021, an estimated 10.6 million people fell ill with TB and 1.6 million died—about 4,300 people per day. The disease primarily affects people in low- and middle-income countries, and those at highest risk are often living in poverty, with poor living and working conditions and undernutrition. Up to a quarter of the world's population is thought to have latent TB, a condition in which a person is infected with the bacterium that causes TB but does not have any symptoms and is at risk of…
PR Newswire
28/06/2023

NFL BIOSCIENCES : RESULTS OF THE COMBINED GENERAL MEETING OF JUNE 27, 2023

NFL BIOSCIENCES : RESULTS OF THE COMBINED GENERAL MEETING OF JUNE 27, 2023Appointment of a new director satisfying the independence criteria of the Middlenext CodeNFLBIOSCIENCES(EuronextGrowthParis–FR0014003XT0–ALNFL),a biopharmaceutical company developing botanical medicines for the treatment of dependencies and addictions, held its Joint General Meeting on June 27, 2023 in Montpellier under the chairmanship of Ignacio Faus ,...
Nasdaq GlobeNewswire
28/06/2023
Altri  Comunicati